Even when the margin is negative (as accurately as can be established), the local recurrence is still high, especially in the cases of triple-negative breast cancer, which test negative for estrogen receptor (ER), progesterone receptor (PR) and hormone epidermal growth factor receptor 2 (HER2), significantly limiting targeting and evaluations of this tumor type. The gene discussed is ERBB2; the disease is neoplasm.